Table 1

Gender and age distribution and the prevalence of CVD risk factors of the study participants (n=563)

Age group (years)
31–4950–5960–69≥70Total n (%)Mean±SD
Gender
 Male152 (40.9)116 (31.2)74 (19.9)30 (8.1)372 (66.1)51.9±10.6
 Female110 (57.6)47 (24.6)23 (12.0)11 (5.8)191 (33.9)47.7±10.8
 Total n (%)262 (46.5)163 (29.0)97 (17.2)41 (7.3)563 (100)50.5±10.9
VariablesPrevalence of CVD risk factors % (95% CI)
 *HTN5.3 (3.0 to 8.8)6.7 (3.4 to 11.8)20.6 (13.1 to 30.0)14.6 (5.6 to 29.2)9.1 (6.8 to 11.7)
 †DM2.0 (0.6 to 4.4)1.8 (0.4 to 5.3)5.2 (1.7 to 11.6)2.7 (0.6 to 12.9)2.7 (1.5 to 4.3)
 ‡HC15.3 (11.1 to 20.2)22.7 (16.5 to 29.9)22.7 (14.8 to 32.3)7.3 (1.5 to 19.9)18.1 (15.0 to 21.6)
 Smoking68.7 (62.7 to 74.3)79.8 (72.8 to 85.6)84.5 (75.8 to 91.1)85.4 (70.8 to 94.4)75.8 (72.1 to 79.3)
  • *HTN (ie, SBP ≥140 mm Hg).

  • †DM (ie, fasting blood glucose ≥7.0 mmol/L).

  • ‡HC (ie, fasting blood cholesterol ≥6.0 mmol/L).

  • CVD, cardiovascular disease; DM, diabetes mellitus HC, high cholesterol; HTN, hypertension.